APCER Pharma Solutions, Inc.

APCER Pharma Solutions, Inc. President and CEO Suneet Walia Comments on FDA Proposed Mandatory Electronic Safety Reporting Program

Published in Drug Law Weekly, September 22nd, 2009

APCER Pharma Solutions, Inc. ("APCER") President and CEO Suneet Walia commented on the US Food and Drug Administration's (FDA) proposed rules to amend postmarket safety reporting regulations for three of its centers, to require manufacturers and other facilities subject to current reporting requirements to submit their reports electronically.

APCER is a leading provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

In response to these proposed changes, Mr. Walia commented, "This is a significant and ultimately a positive step that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2009-09-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database